Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study (Q34525613)

2 August 2017

Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study (English)

1 reference

Helicobacter pylori infectious disease

2 August 2017

0 references

1 reference

Vicente R

1

1 reference

2 August 2017

Sicilia B

2

1 reference

2 August 2017

Gallego S

3

1 reference

2 August 2017

Revillo MJ

4

1 reference

2 August 2017

Ducóns J

5

1 reference

2 August 2017

Gomollón F

6

1 reference

2 August 2017

language of work or name

1 reference

1 August 2002

1 reference

Gastroenterología y Hepatología

2 August 2017

1 reference

2 August 2017

25

1 reference

2 August 2017

7

1 reference

2 August 2017

438-442

1 reference

Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

The ideal therapy must be defined in each geographical area: experience with a quadruple therapy in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Eradication of Helicobacter pylori and non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Regular review: treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Unhealed duodenal ulcers despite Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Eradication of Helicobacter pylori Infection With Proton Pump-Based Triple Therapy in Patients in Whom Bismuth-Based Triple Therapy Failed

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

Helicobacter pylori: strategies for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

In vitro activity of rifabutin against strains of Helicobacter pylori resistant to metronidazole and clarithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0210-5705%2802%2970283-5

7 January 2021

10.1016/S0210-5705(02)70283-5

Identifiers

DOI

1 reference

2 August 2017

1 reference